Define the users and their critical tasks
An ergonomic injection pen should be evaluated in relation to its intended users and environment. People may differ in vision, dexterity, experience, language and access to caregiver support. A comfortable grip in a design review does not show that users can identify the correct product, prepare it, set a dose and recognize completion. Map the complete task sequence and identify where errors could affect safety. FDA’s human factors guidance provides context for evaluating device users, interfaces and use environments. For procurement, ask what user evidence exists for the proposed configuration and what would need to be repeated after a change. Keep patient groups specific. A claim that a pen is suitable for children, older adults or people with visual impairment requires more than a larger label or a brighter color.
Treat labeling and training as parts of the interface
The interface includes the instructions, package, labels and feedback as well as the physical device. A private-label change can alter product recognition, contrast, language or the interpretation of a control. Review the complete presentation rather than approving artwork separately from engineering. Training materials should show the intended model and current sequence, including what to do when something does not proceed as expected. Do not reuse generic injection instructions across unrelated devices. For a B2B review, ask suppliers to identify the assumptions behind any usability study and the differences between the studied version and the proposed version. A useful project record links each meaningful design change to an assessment of its potential effect on users. This makes the evidence more useful than an unsupported easy-to-use claim on a product page.
Parameters & review checklist
- Intended users and environment
- Critical tasks and foreseeable errors
- Labeling and training version
- Evidence for changed configurations
Apply this guide to your project
Use these configuration briefs to record the requirements discussed above, then prepare the document and quotation requests for your project.
Platform comparison and downloadable buyer worksheets ↗
Sample references and supplier evidence checklist ↗
Common questions
Can a larger grip prove suitability for low dexterity?
No. The complete task sequence should be evaluated with representative users and the intended presentation.
Sources & further reading
- FDA: human factors and usability engineering Reference page checked 28 October 2026.
External references describe their publishers’ products or guidance. Procurement tables are editorial decision aids; they do not establish conformity of a Hytanbio-Tech configuration.
Continue exploring
Which human factors guidance editions should a project review?
Check FDA’s August 2026 final human factors guidance together with its May 2026 companion on marketing submission information. The device users, intended tasks, use environments and risk analysis determine what evidence is relevant to the proposed presentation.
These publications do not approve a catalog pen or make a usability claim transferable between configurations. Keep the studied device, labeling and training revisions attached to the project record, and assess whether a private-label or component change affects the evidence.
- FDA — Applying Human Factors and Usability Engineering to Medical Devices — Final guidance, August 2026; intended users, uses, environments and use-related risk.
- FDA — Content of Human Factors Information in Medical Device Marketing Submissions — Final guidance, May 2026; risk-based submission information.
Source editions checked 28 October 2026.